Drug-induced glaucoma is a form of secondary glaucoma. Several types of drugs, such as adrenergic agonists, cholinergics, anti-cholinergics, sulfa-based drugs (e.g. topiramate), selective serotonin reuptake inhibitors, tricyclic and tetracyclic anti-depressants, anticoagulants, and antihistamines, have been reported to induce secondary acute angle-closure glaucoma [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12].
Cabergoline (brand names Dostinex and Cabaser), an ergot derivative, is a potent dopamine D2 receptor agonist. The drug is prescribed in Parkinson’s disease, prolactin-producing pituitary gland tumors, ablactation and dysfunctions associated with hyperprolactinemia. It stimulates dopamine receptors in lactophilic hypothalamic cells to suppress prolactin secretion in the pituitary gland